Tag Archives: fda

Breaking News: Bayer Discontinues Sales of Birth Control Device Essure

By the end of 2018, Bayer HealthCare will stop selling Essure—a contraceptive device that has caused severe injuries and complications for thousands of women. Marketed as a permanent, nonsurgical method of contraception, Essure has caused debilitating adverse side-effects including chronic pain, pregnancy, miscarriage, perforation of the uterus or other organs, and...
Read more

$70 Million in Damages Awarded in Risperdal Gynecomastia Suit

In one of the latest verdicts in the Risperdal litigation, on July 1, 2016 a Pennsylvania jury ordered manufacturer Johnson & Johnson to pay $70 million in damages to a teenager. The teen claims that after taking the antipsychotic drug as a boy, he later developed female-like breasts—a side-effect called gynecomastia that the...

Read more

FDA’s Essure Safety Review Revealed in February

Come February 2016, the FDA will decide what action to take over Bayer’s permanent birth control device Essure. The official safety review will be based on information gathered at the FDA’s Obstetrics and Gynecology Devices Panel held this past September in addition to numerous studies and scientific data. The Panel meeting was convened this...

Read more

Microbead-Free Waters Act Spills Over to Essure Birth Control Device

In January 2016, Congress enacted the “Microbead-Free Waters Act of 2015” that is intended to stop the manufacturing of rinse-off cosmetics that contain intentionally-added plastic microbeads, and may prompt a closer inspection of similar products including polyethylene terephthalate fibers, or PET fibers, which are used in Bayer’s Essure birth control device. According to Read more

Real Time Analytics